Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.27% Nasdaq Up0.16%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS

9.26 Up 0.13(1.42%) 11:24AM EDT - Nasdaq Real Time Price

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 12,719   16,613   10,387  
Cost of Revenue8,100  7,414  6,536  
Gross Profit 4,619   9,199   3,851  
Operating Expenses
Research Development58,706  75,459  110,159  
Selling General and Administrative24,248  27,936  25,247  
Non Recurring3,467   -  3,324  
Others997  2,159  3,508  
Total Operating Expenses87,418   -  142,238  
Operating Income or Loss (82,799) (96,355) (138,387)
Income from Continuing Operations
Total Other Income/Expenses Net(12,116)(6,498)3,901  
Earnings Before Interest And Taxes(94,915)(102,853)(134,486)
Interest Expense14,309  21,681  18,718  
Income Before Tax(109,224)(124,534)(153,204)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(119,738)(136,888)(155,683)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (109,224) (124,534) (153,204)
Preferred Stock And Other Adjustments(2,260) -   -  
Net Income Applicable To Common Shares (111,484) (124,534) (153,204)

Currency in USD.